Eckert & Ziegler Radiopharma (Cyclotron Division) is Other Healthcare Technology Systems in Germany that focus on particle acceleration technology business. They cover business area such as developer, particle acceleration technology, particle beam, outward, scientist, pharmaceutical industry, physics, nuclear medicine.
Other Healthcare Technology Systems
-
Particle Acceleration Technology
-
Robert-Rössle-Straße 10
13125 Berlin
Germany
Private
developerparticle acceleration technologyparticle beamoutwardscientistpharmaceutical industryphysicsnuclear medicine
* We use standard office opening hours in near Eckert & Ziegler Radiopharma (Cyclotron Division)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Eckert & Ziegler Radiopharma (Cyclotron Division) is Other Healthcare Technology Systems business from Germany that founded in - ( years old in ), Eckert & Ziegler Radiopharma (Cyclotron Division) business is focusing on Particle Acceleration Technology.
Eckert & Ziegler Radiopharma (Cyclotron Division) headquarter office and corporate office address is located in Robert-Rössle-Straße 10 13125 Berlin Germany.
Eckert & Ziegler Radiopharma (Cyclotron Division) was founded in Germany.
In , Eckert & Ziegler Radiopharma (Cyclotron Division) is currently focus on particle acceleration technology sector.
Above is snippet of Google Trends for "particle acceleration technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Eckert & Ziegler Radiopharma (Cyclotron Division), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.